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JeffCARE Diabetes Mellitus Abstract Study
__________________________________________
JeffCARE, in collaboration with The Center for Research in Medical Education and
Health Care (CRMEHC), developed a survey instrument, and conducted a chart
review study of selected patients with diabetes mellitus during the spring of 1999.
This effort is one of the first major cooperative projects of the Jefferson Health
System’s Disease Management Committee, a subset of the Jefferson Health System
(JHS) Quality Council led by Stanton N. Smullens, MD, Chief Medical Officer, JHS.
Diabetes was chosen as the focus of this project because of its significant prevalence
in our region, the high direct and indirect costs of this disease, and the consensus
that outcomes can be improved with “population-based” disease management
principles. American Diabetes Association (ADA) guidelines were used as the basis
for the instrument.
The goals of the project were threefold: 1) To provide baseline information on the
diabetic full risk sub-population within the Jefferson Health System. 2) To provide
feedback to physicians/practices on their conformity to recommended ADA
guidelines. 3) To create a patient database which would allow reevaluation after a
fixed period of time, and additionally provide a resource for further study. In
addition, Aetna US Healthcare’s research and data division, US Quality Algorithms,
has expressed interest in a collaborative research effort.
The study questionnaire was designed with multidisciplinary clinical input from
throughout the JHS. The survey explored the major ADA/NCQA (National Committee
on Quality Assurance) collaborative provider recognition components: glycemic
control, lipid management, urinary microalbuminuria levels, use of ACE inhibitors
when necessary, HbA1c levels, and dilated eye exams yearly, as examples.
Demographic data and linking codes for follow-up, as well as practice/MD/system
identifiers for easy sorting and report generation was included.
The form was developed at the CRMEHC using newly available technology, which
allows for hand written data, e.g., dates and lab values, to be scanned directly into a
data file for processing. There are significant advantages of this system, compared to
the standard “bubbling” method. These data are easier to enter and take up less
space on the form. More importantly however, study questions based on time
intervals and threshold values can be reviewed and modified after all the data have
been collected. Easy access to actual, rather than circumscribed, information greatly
expands the research possibilities. Pertinent questions regarding adherence to
national guidelines can be asked. For example, dates can be recorded to determine if
the patient had an eye or foot exam within one year.
Selection of patients for inclusion in this study was done by various methods. The
JeffCARE and Main Line Health Aetna US Healthcare risk patients were sorted using
an algorithm that filters claims information from among ICD-9 diagnoses, laboratory
data such as hemoglobin A1c, and pharmacy information , such as scripts for insulin
or oral hypoglycemic. Such information can be derived directly from the
insurer/partner or internal practice management information such as IDX. JeffCARE
chose to study its entire population of diabetics in the risk population. The other
partners in the system limited their reviews to certain large practices, usually 100200 total patients.
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Overall, a database of 1,016 patients was reviewed: 569 from JeffCARE, 142 from
Main Line Health, 202 from Albert Einstein M e d i c a l Center and 103 from Frank
ford Health System. More than 50% of patients were in the practice for at least 5
years. Over 70% were seen in the office within 3 months of the chart review date.
While the age range of patients was 3 to 97, 83% were between 40-80. Insulin is
prescribed for 39%, while 67% are using oral hypoglycemic agents.
It is possible that incomplete record keeping contributed to the study results, which
may understate the actual numbers of laboratory tests ordered, and of screening
examinations being performed for diabetic complications. This is particularly
important where care may be provided by another physician , such as an
ophthalmologist performing a dilated eye exam, or a test that a patient has had
performed at a lab outside of the system.
We have shared the results of each office’s performance with our providers. Initial
feedback has been excellent. Providers have appreciated the help in identifying areas
for improvement. This has led to innovative new chart maintenance strategies.
Office staffs have become more familiar with the network care management team,
which is an additional spin-off benefit of this effort. It has also opened the door for
the facilitation of provider and patient education models over the next year.
Future efforts will involve more uniform randomization of charts throughout the
health system. This will also benefit the Quality Council’s efforts to include specific
measures of improvement in the ambulatory setting. We are also studying a similar
model for asthma management. For additional information about this study design
and related disease management matters, please contact Dr. Jeffrey Lenow at
JeffCARE (Physician Hospital Organization of Thomas Jefferson University Hospital)
(215-955-8774), email: jeffrey.lenow@mail.tju.edu. For more general information on
the survey instrument development and scanning technologies employed please
contact Kaye Maxwell at the Center for Research in Medical Education and Health
Care (215-955-6907).
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